Delivery Order SPE2DB24D8003-SPE2DB25FJULZ
Award Date
5/22/25
Potential Completion Date
5/23/25
Potential Value
$2.8K
Federal Agency
Defense Logistics Agency
Awardee
Dakota Drug, Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $4,006.26 to Dakota Drug, Inc., a self-certified small disadvantaged business, to provide Aimovig 140 mg/mL autoinjectors. This contract has a completion date of February 5, 2025 and is not set-aside. Dakota Drug, Inc. is a key supplier of pharmaceutical products, medical supplies, and healthcare equipment to the U.S. federal government, particularly the Department of Defense. The company holds a...
This is a $1,532.07 firm fixed-price delivery order contract awarded to Dakota Drug, Inc., a self-certified small disadvantaged business, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of AIMOVIG 70 MG/ML autoinjectors, a pharmaceutical product, with a performance period through November 25, 2024. This award is associated with Dakota Drug, Inc.'s larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA, which is part of the DLA Troop...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The contract is for the delivery of AIMOVIG 140 MG/ML AUTOINJECTORML, a pharmaceutical product. The contract has a ceiling value of $3,603.77 and a performance period through May 9, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical's ECAT Generation V...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of the pharmaceutical product AIMOVIG 140 MG/ML AUTOINJECTORML. The contract, with a ceiling value of $2,846.52, is a firm fixed price delivery order contract that runs through December 6, 2024. Dakota Drug, Inc. is the prime contractor for this award and holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is a Delivery Order valued at $2,528.44 and has a firm fixed price pricing type. It is not a set-aside contract. The contract is for the provision of pharmaceutical products, specifically Aimovig 140 mg/ml autoinjectors, to support U.S. Armed Forces medical operations. Dakota Drug, Inc. holds a larger Indefinite Delivery Contract (IDC) with...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The $2,856.72 firm fixed price contract is for the supply of AIMOVIG 140 MG/ML AUTOINJECTORML, a pharmaceutical product, to support DLA Troop Support Medical's operations and military treatment facilities. No major subcontractors were indicated. This delivery...
This federal contract award, identified as SPE2DB24D8001 and SPE2DB25FKZHX, was granted by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is a Delivery Order valued at $1,667.25 with a Firm Fixed Price pricing type and an ultimate completion date of March 10, 2025. The contract is for the provision of AIMOVIG 140 MG/ML AUTOINJECTORML, a pharmaceutical product, to support the medical operations of the U.S. Armed Forces....
This firm fixed-price delivery order contract was awarded by the Department of Defense (DoD), specifically the Defense Logistics Agency (DLA) Troop Support Medical, to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The contract, valued at $2,717.38, is for the supply of the prescription medication AIMOVIG 140 MG/ML AUTOINJECTORML. The contract has an ultimate completion date of May 14, 2024 and was awarded on May 13, 2024...
This federal contract award, identified as SPE2DX15D8002|SPE2DX24F2WJ7, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $3,517.49 firm fixed-price delivery order is for the provision of AIMOVIG 70 MG/ML AUTOINJECTORML, a pharmaceutical product, with a performance period ending on May 21, 2024. The contract is not associated with a set-aside designation. Dakota Drug, Inc. holds a significant single-award Indefinite Delivery...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business, for the supply of the pharmaceutical product Aimovig 70 mg/ml autoinjector. The contract has a ceiling value of $1,866.28 and a period of performance through April 22, 2024. This award is not associated with a set-aside designation. Dakota Drug, Inc. has over two decades of experience providing a wide range...